Botanical

Feverfew

Also called Tanacetum parthenium, MIG-99

By Kymata Labs EditorialMedical review pendingLast reviewed October 11, 2026 · What changed

Kymata Health may earn a commission from links on separate product pages. This page contains no product links. Educational reference, not medical advice.

Summary

Feverfew is a daisy-family herb taken to cut down migraine attacks. The largest trial found 0.6 fewer attacks a month than placebo, and a Cochrane review rated the overall evidence low quality and mixed. Side effects were mild, mainly stomach complaints and mouth ulcers. It should not be used in pregnancy, may slow clotting, and can cause allergy in people sensitive to ragweed.

Top graded outcomes:C evidence grade Migraine attacks per monthC evidence grade Migraine frequency

Key facts

What it is
A perennial daisy-family herb native to western Asia and the Balkans, different from American feverfew[1]
Migraine, best trial
Attacks fell from 4.8 to 2.9 a month on feverfew extract versus 4.8 to 3.5 on placebo, a difference of 0.6 attacks a month[3][2]
Overall evidence
Cochrane: 6 trials (561 patients), mixed results, low-quality evidence[2]
Safety
Mild gastrointestinal effects and mouth ulcers; ragweed allergy, slowed clotting and pregnancy are the main cautions[2][1]
Evidence base
2 graded human outcomes on this page
Last reviewed
October 11, 2026

How it works

ProposedHow feverfew might reduce migraine attacks is not established in the sources cited here.[2]

What the human research says

Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.

Form tested
Sort

Showing 2 of 2 outcomes. Human trials only.

OutcomeEffectGradeBest evidencePMID
Migraine frequencyMixedGrade C

Systematic review · n = 561 · 2015

People with migraine in 6 double-blind trials

Form: Feverfew monopreparations · Dose: Varied across trials · Duration: Varied across trials

Results could not be pooled; small trials were positive, two rigorous trials found no difference, and the largest trial found 0.6 fewer attacks a month. Evidence was rated low quality.

25892430 (opens PubMed)Source [2]
Migraine attacks per monthImprovedGrade C

RCT · n = 170 · 2005

Adults with migraine (International Headache Society criteria)

Form: Feverfew CO2 extract (MIG-99) · Dose: 6.25 mg three times daily · Duration: 16 weeks

Attacks fell by 1.9 a month versus 1.3 on placebo (P=0.046); responders were more likely on feverfew (odds ratio 3.4), and possibly related adverse events were similar (8.4% vs 10.2%).

16232154 (opens PubMed)Source [3]

Forms

FormElemental %Absorption (human data)GI toleranceStudied for
Feverfew leaf extract (capsules)VariesNot applicable (botanical extract)No head-to-head human absorption data in the sources cited here.Mild gastrointestinal complaints and mouth ulcers in trials.[2]Migraine-prevention trials
Fresh leaves (chewed)VariesNot applicableNot studied in the sources cited here.Chewing fresh leaves can cause mouth sores and irritation.[1]Traditional use

Studied doses

Doses studied in human trials ranged from 6.25 mg of a standardized CO2 extract three times daily (18.75 mg/day) for 16 weeks in the largest trial; other trials used different preparations and doses.[3][2]

These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Interactions

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

Medicines

  • Migraine medicinesNIH fact sheetNCCIH notes feverfew may interact with some medicines, including those used for migraine.[1]

Who should be careful

Pregnancy
NCCIH advises against feverfew in pregnancy because it may affect uterine contractions.[1]
Before surgery
Feverfew may slow blood clotting; NCCIH says to stop at least 2 weeks before scheduled surgery.[1]
Ragweed allergy
People sensitive to ragweed and related plants may react to feverfew.[1]

Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

Frequently asked questions

Does feverfew reduce migraines?

Possibly, slightly: the largest trial found 0.6 fewer attacks a month than placebo, and overall evidence is mixed and low quality.[3][2]

Is feverfew safe?

Trial side effects were mild, mainly stomach complaints and mouth ulcers, but it is not for use in pregnancy and may slow clotting.[2][1]

How much feverfew was studied?

The largest trial used 6.25 mg of a CO2 extract three times a day for 16 weeks.[3]

Is American feverfew the same plant?

No. American feverfew (Parthenium integrifolium) is a different plant.[1]

Sources

  1. [1]Feverfew (last updated February 2025). National Center for Complementary and Integrative Health, 2025. fact-sheet
  2. [2]Feverfew for preventing migraine. Cochrane Database Syst Rev, 2015. systematic-review PMID 25892430
  3. [3]Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia, 2005. RCT PMID 16232154

What changed

  1. October 11, 2026 · all · new page (encyclopedia expansion, A–L)New monograph. Every PMID checked against NCBI E-utilities (title, journal and year from the PubMed record); each evidence row written from its abstract; intake and safety facts from the cited fact sheets.Writer: Kymata Labs Editorial · No credentialed reviewer yet

How we write, grade and correct these pages: editorial and evidence policy.

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Supplements and vitamins: every page →Supplement & Nutrient Encyclopedia →Browse all topics →

Evidence-graded supplement stacks →